Avaleht › Vähk (kõik liigid) › Ohio › Cincinnati
Vähk (kõik liigid) kliinilised uuringud linnas Cincinnati, OH
27 uuringut haiguse Vähk (kõik liigid) jaoks otsivad osalejaid linnas Cincinnati ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
VärbamineFaas 2
- University of Cincinnati Medical Center. /ID# 278925, Cincinnati
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
VärbamineFaas 3
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · 15 mi kaugusel
Registry Study for Radiation Therapy Outcomes
VärbamineVaatlusuuring
- University of Cincinnati Medical Center, Cincinnati
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
VärbamineFaas 3
- Saint Elizabeth Medical Center Edgewood, Edgewood · 8 mi kaugusel
A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
Värbamine
- Cincinnati Children's Hospital Medical Center, Cincinnati
Pan Tumor Rollover Study
VärbamineFaas 2
- Oncology Hematology Care, Cincinnati
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
VärbamineFaas 3
- Oncology Hematology Care - Fairfield /ID# 280641, Fairfield · 15 mi kaugusel
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
VärbamineFaas 2
- University of Cincinnati Medical Center, Cincinnati
- West Chester Hospital, West Chester · 15 mi kaugusel
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
VärbamineFaas 2/3
- Oncology Hematology Care, Inc., Cincinnati
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
VärbamineFaas 3
- Research Site, Edgewood · 8 mi kaugusel
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
VärbamineFaas 3
- USO - Oncology Hematology Care, Cincinnati
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
VärbamineVaatlusuuring
- University of Cincinnati, Cincinnati
Project: Every Child for Younger Patients With Cancer
VärbamineVaatlusuuring
- Cincinnati Children's Hospital Medical Center, Cincinnati
International Rare Brain Tumor Registry
VärbamineVaatlusuuring
- Cincinnati Children's Hospital Medical Center, Cincinnati
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
VärbamineFaas 3
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- ja veel 1
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
VärbamineFaas 3
- University of Cincinnati Physicians Group, LLC, Cincinnati
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
VärbamineFaas 1/2
- Oncology Hematology Care - Blue Ash /ID# 272918, Cincinnati
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
VärbamineFaas 1
- University Of Cincinnati Medical Center /ID# 251746, Cincinnati
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
VärbamineVaatlusuuring
- TriHealth Cancer Institute, Cincinnati
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
VärbamineFaas 1/2
- University of Cincinnati, Cincinnati
Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors
VärbamineFaas 2
- University of Cincinnati Medical Center, Cincinnati
GEMINI-NSCLC: NSCLC Biomarker Study
VärbamineVaatlusuuring
- TriHealth Cancer Institute, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
VärbamineVaatlusuuring
- Massive Bio SYNERGY-AI site, Cincinnati
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
VärbamineFaas 1
- The Christ Hospital Cancer Center, Cincinnati
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
VärbamineVaatlusuuring
- University of Cincinnati Medical Center, Cincinnati
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
VärbamineVaatlusuuring
- TriHealth Cancer Institute, Cincinnati
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Värbamine
- University of Cincinnati, Cincinnati
- West Chester Hospital (OH394), West Chester · 15 mi kaugusel
Vähk (kõik liigid) uuringud teistes linnades
- Houston, TX121 uuringut
- New York City, NY110 uuringut
- Boston, MA86 uuringut
- Los Angeles, CA73 uuringut
- Nashville, TN65 uuringut
- Philadelphia, PA59 uuringut
- Durham, NC58 uuringut
- Washington, DC58 uuringut
- Chicago, IL51 uuringut
- Seattle, WA49 uuringut
- Atlanta, GA49 uuringut
- Arlington, VA48 uuringut
Muud uuringud linnas Cincinnati
- Mitteväikerakuline kopsuvähk35 uuringut
- Rinnavähk25 uuringut
- Südamepuudulikkus24 uuringut
- Käär- ja pärasoolevähk21 uuringut
- Äge müeloidne leukeemia20 uuringut
- Metastaatiline vähk20 uuringut
- Munasarjavähk19 uuringut
- Kopsuvähk19 uuringut
- Rasvumine19 uuringut
- Eesnäärmevähk18 uuringut
- Müeloom17 uuringut
- Melanoom17 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.